Literature DB >> 23055049

Current treatment of selected pediatric sleep disorders.

Shannon S Sullivan1.   

Abstract

While pediatric sleep disorders are relatively common, treatments are often not straightforward. There is often a paucity of gold standard studies and data available to guide clinicians, treatments may yield arguably incomplete results, interventions may require chronic use, and/ or involve multiple modalities including behavioral interventions that require high parental and family commitment. This review points out diagnostic differences compared to adults and focuses on current therapy for selected common pediatric sleep disorders including sleep disordered breathing/ obstructive sleep apnea, narcolepsy, and restless legs syndrome. Other common pediatric sleep disorders, such as insomnia and parasomnias, are not covered.

Entities:  

Mesh:

Year:  2012        PMID: 23055049      PMCID: PMC3480565          DOI: 10.1007/s13311-012-0149-2

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  113 in total

1.  Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency.

Authors:  Stine Knudsen; Bo Biering-Sørensen; Birgitte R Kornum; Eva R Petersen; Jette D Ibsen; Steen Gammeltoft; Emmanuel Mignot; Poul J Jennum
Journal:  Neurology       Date:  2012-06-20       Impact factor: 9.910

Review 2.  Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature.

Authors:  Samuele Cortese; Eric Konofal; Michel Lecendreux; Isabelle Arnulf; Marie-Christine Mouren; Francesca Darra; Bernardo Dalla Bernardina
Journal:  Sleep       Date:  2005-08-01       Impact factor: 5.849

3.  Systemic inflammation in non-obese children with obstructive sleep apnea.

Authors:  David Gozal; Laura D Serpero; Oscar Sans Capdevila; Leila Kheirandish-Gozal
Journal:  Sleep Med       Date:  2007-09-06       Impact factor: 3.492

4.  Toxicity from modafinil ingestion.

Authors:  Henry A Spiller; Douglas Borys; Jill R K Griffith; Wendy Klein-Schwartz; Alfred Aleguas; Dawn Sollee; Deborah A Anderson; Tama S Sawyer
Journal:  Clin Toxicol (Phila)       Date:  2009-02       Impact factor: 4.467

5.  Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome.

Authors:  Svenja Happe; Cornelia Sauter; Gerhard Klösch; Bernd Saletu; Josef Zeitlhofer
Journal:  Neuropsychobiology       Date:  2003       Impact factor: 2.328

6.  A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.

Authors:  Manijeh Kahbazi; Aboulfazl Ghoreishi; Fatemeh Rahiminejad; Mohammad-Reza Mohammadi; Abbas Kamalipour; Shahin Akhondzadeh
Journal:  Psychiatry Res       Date:  2009-05-12       Impact factor: 3.222

7.  Efficacy of automated continuous positive airway pressure in children with sleep-related breathing disorders in an attended setting.

Authors:  Luciana Palombini; Rafael Pelayo; Christian Guilleminault
Journal:  Pediatrics       Date:  2004-05       Impact factor: 7.124

Review 8.  Treatment of narcolepsy and other hypersomnias of central origin.

Authors:  Merrill S Wise; Donna L Arand; R Robert Auger; Stephen N Brooks; Nathaniel F Watson
Journal:  Sleep       Date:  2007-12       Impact factor: 5.849

9.  Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy.

Authors: 
Journal:  Sleep Med       Date:  2004-03       Impact factor: 3.492

10.  Hypoxemia and obesity modulate plasma C-reactive protein and interleukin-6 levels in sleep-disordered breathing.

Authors:  Riva Tauman; Louise M O'Brien; David Gozal
Journal:  Sleep Breath       Date:  2007-06       Impact factor: 2.655

View more
  3 in total

1.  The treatment of sleep disorders.

Authors:  Rafael Pelayo; Emmanuel Mignot
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

Review 2.  Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain.

Authors:  Kimberly R Urban; Wen-Jun Gao
Journal:  Front Syst Neurosci       Date:  2014-05-13

Review 3.  Pharmacological Human Enhancement: An Overview of the Looming Bioethical and Regulatory Challenges.

Authors:  Giovanna Ricci
Journal:  Front Psychiatry       Date:  2020-02-17       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.